Shenzhen Kexing Pharmaceutical Co., Ltd.
Quick facts
Phase 3 pipeline
- SHEN26 capsule · Infectious Disease
SHEN26 capsule is a vaccine that targets the SARS-CoV-2 spike protein.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: